Spencer Proctor trained as a physiologist and cardiovascular scientist in both Australia and Canada. He was appointed at the Alberta Institute for Human Nutrition at the University of Alberta in 2004 and founded the Metabolic and Cardiovascular Diseases (MCVD) Laboratory. His research program spans a unique continuum of expertise in the areas of nutrition, metabolism, physiology, behavior, food health, and chronic disease. His areas of focus include absorption/metabolism of dietary lipids in health, cardiovascular risk, and the metabolic syndrome; interaction of lipids with arterial vessels during atherosclerosis and insulin resistance; novel bioactivity of dietary fatty acids and impact to the metabolic syndrome. His research highlights include the following. He has been one of the first researchers to provide visual evidence that intestinally derived cholesterol particles (chylomicrons) penetrate arterial tissue after hydrolysis to their smaller remnant form and therefore contribute to the atherogenic process. He has developed a model of overproduction of intestinal derived cholesterol particles (lipoproteins) during insulin resistance that is thought to contribute to dyslipidemia and CVD risk. He has discovered lipid lowering properties of trans-11 vaccenic acid, a ruminant (natural) transfat that is commonly found in dairy products.
Biography Updated on 31 July 2013